185 Early results of a phase II study of oral topotecan and intravenous cisplatin in epithelial ovarian cancer recurring more than 6 months following initial platinum therapy
Jasas, K., Trudeau, M., Stuart, G., Gillesby, B.E., Fields, N., Oza, A.
Published in European journal of cancer supplements (01.09.2003)
Published in European journal of cancer supplements (01.09.2003)
Get full text
Journal Article